819 related articles for article (PubMed ID: 14585926)
1. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.
Yang H; Yang M; Ding Y; Liu Y; Lou Z; Zhou Z; Sun L; Mo L; Ye S; Pang H; Gao GF; Anand K; Bartlam M; Hilgenfeld R; Rao Z
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13190-5. PubMed ID: 14585926
[TBL] [Abstract][Full Text] [Related]
2. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the maturation process of SARS-CoV 3CL protease.
Hsu MF; Kuo CJ; Chang KT; Chang HC; Chou CC; Ko TP; Shr HL; Chang GG; Wang AH; Liang PH
J Biol Chem; 2005 Sep; 280(35):31257-66. PubMed ID: 15788388
[TBL] [Abstract][Full Text] [Related]
6. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
[TBL] [Abstract][Full Text] [Related]
7. Drug design targeting the main protease, the Achilles' heel of coronaviruses.
Yang H; Bartlam M; Rao Z
Curr Pharm Des; 2006; 12(35):4573-90. PubMed ID: 17168763
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
Wu CG; Cheng SC; Chen SC; Li JY; Fang YH; Chen YH; Chou CY
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):747-55. PubMed ID: 23633583
[TBL] [Abstract][Full Text] [Related]
9. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.
Hsu WC; Chang HC; Chou CY; Tsai PJ; Lin PI; Chang GG
J Biol Chem; 2005 Jun; 280(24):22741-8. PubMed ID: 15831489
[TBL] [Abstract][Full Text] [Related]
10. Activation and maturation of SARS-CoV main protease.
Xia B; Kang X
Protein Cell; 2011 Apr; 2(4):282-90. PubMed ID: 21533772
[TBL] [Abstract][Full Text] [Related]
11. C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer.
Zhong N; Zhang S; Xue F; Kang X; Zou P; Chen J; Liang C; Rao Z; Jin C; Lou Z; Xia B
Protein Sci; 2009 Apr; 18(4):839-44. PubMed ID: 19319935
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
Ratia K; Saikatendu KS; Santarsiero BD; Barretto N; Baker SC; Stevens RC; Mesecar AD
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5717-22. PubMed ID: 16581910
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.
Lu IL; Mahindroo N; Liang PH; Peng YH; Kuo CJ; Tsai KC; Hsieh HP; Chao YS; Wu SY
J Med Chem; 2006 Aug; 49(17):5154-61. PubMed ID: 16913704
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.
Takeda-Shitaka M; Nojima H; Takaya D; Kanou K; Iwadate M; Umeyama H
Chem Pharm Bull (Tokyo); 2004 May; 52(5):643-5. PubMed ID: 15133227
[TBL] [Abstract][Full Text] [Related]
15. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
Lee CC; Kuo CJ; Ko TP; Hsu MF; Tsui YC; Chang SC; Yang S; Chen SJ; Chen HC; Hsu MC; Shih SR; Liang PH; Wang AH
J Biol Chem; 2009 Mar; 284(12):7646-55. PubMed ID: 19144641
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
[TBL] [Abstract][Full Text] [Related]
19. 1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain.
Zhang S; Zhong N; Ren X; Jin C; Xia B
Biomol NMR Assign; 2011 Oct; 5(2):143-5. PubMed ID: 21181312
[TBL] [Abstract][Full Text] [Related]
20. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.
Shi J; Wei Z; Song J
J Biol Chem; 2004 Jun; 279(23):24765-73. PubMed ID: 15037623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
